Skip to main content

Insurance, Medicare & Medicaid

Health care coverage, from private insurance to employer-provided health care to public programs like Medicare and Medicaid, can have various impacts on people’s use of health care and, ultimately, their health and well-being.

Blog Post       The Role of Employers (and Employees) in the Health Spending Conversation

The Role of Employers (and Employees) in the Health Spending Conversation

As partners in the Going Below The Surface Forum, AcademyHealth and the National Pharmaceutical Council (NPC) consider the drivers of health spending in the U.S. through salons focused on challenging questions. Today’s post takes a closer look at strategies to reduce costs via employer-sponsored health benefits.
Blog Post       Moving to Value-Based Care is a Marathon We’ve Barely Begun

Moving to Value-Based Care is a Marathon We’ve Barely Begun

This ‘plain language summary’ considers a recent commentary from Zirui Song, M.D., Ph.D., in HSR, an official journal of AcademyHealth, that offers a broad review of the state of the science on Accountable Care Organizations, including a brief discussion of three new studies also published in the August issue.
Posted Jul 23, 2021 By Kristin Rosengren
Blog Post       More Research is Essential to Improve Care for Dual-Eligible Beneficiaries

More Research is Essential to Improve Care for Dual-Eligible Beneficiaries

The population dually eligible for Medicare and Medicaid was one of the hardest hit by COVID-19. Arielle Mir of Arnold Ventures, an AcademyHealth organizational member, explains how policymakers are urgently seeking solutions to improve their care and experience, but better data infrastructure and research are needed to achieve meaningful change.
Posted Jul 1, 2021 By Arielle Mir
Blog Post       Study Finds New Cancer Therapies Improved Survival, But Increased Medicare Spending Substantially

Study Finds New Cancer Therapies Improved Survival, But Increased Medicare Spending Substantially

A new study published in HSR, an official journal of AcademyHealth, found that while the use of new cancer therapies did result in noteworthy improvements in lung cancer survival rates, Medicare spending increased substantially, raising concerns about the financial burden of these treatments.
Posted May 19, 2021 By Lauren Adams, M.A.